Proposed Data Collection Submitted for Public Comment and Recommendations, 42299-42300 [2018-17978]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 162 / Tuesday, August 21, 2018 / Notices
of Woodforest Financial Group, Inc.,
The Woodlands, Texas, and thereby
indirectly acquire Woodforest National
Bank, Houston, Texas.
Board of Governors of the Federal Reserve
System, August 16, 2018.
Ann Misback,
Secretary of the Board.
[FR Doc. 2018–17974 Filed 8–20–18; 8:45 am]
BILLING CODE P
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffery M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road, NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
FOR FURTHER INFORMATION CONTACT:
Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60-Day–18–0210; Docket No. CDC–2018–
0069]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
continuing information collection
project titled List of Ingredients Added
to Tobacco in the Manufacture of
Cigarette Products.
DATES: CDC must receive written
comments on or before October 22,
2018.
SUMMARY:
You may submit comments,
identified by Docket No. CDC–2018–
0069 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road, NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(egulations.gov) or by U.S. mail to the
address listed above.
sradovich on DSK3GMQ082PROD with NOTICES
ADDRESSES:
VerDate Sep<11>2014
17:31 Aug 20, 2018
Jkt 244001
Proposed Project
List of Ingredients Added to Tobacco
in the Manufacture of Cigarette
Products—Extension (OMB# 0920–0210
Exp.Date 12/31/2018)—National Center
for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers
for Disease Control and Prevention
(CDC).
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
42299
Background and Brief Description
Cigarette smoking is the leading
preventable cause of premature death
and disability in our Nation. Each year
more than 480,000 deaths occur as the
result of cigarette smoking-related
diseases.
The CDC’s Office on Smoking and
Health (OSH) has the primary
responsibility for the HHS smoking and
health program. Since 1986, as required
by the Comprehensive Smoking
Education Act (CSEA) of 1984, which
amended the Federal Cigarette Labeling
and Advertising Act, 15 U.S.C. 1335a,
CDC has collected information about the
ingredients used in cigarette products.
HHS has delegated responsibility for
implementing the required information
collection to CDC’s OSH. Respondents
are commercial cigarette manufacturers,
packagers, or importers (or their
representatives), who are required by
the CSEA to submit ingredient reports to
HHS on an annual basis.
Respondents are not required to
submit specific forms; however, they are
required to submit a list of all
ingredients used in their products. CDC
requires the ingredient report to be
submitted by chemical name and
Chemical Abstract Service (CAS)
Registration Number, consistent with
accepted reporting practices for other
companies currently required to report
ingredients added to other consumer
products. The information collected is
subject to strict confidentiality
provisions.
Ingredient reports are due annually on
March 31. Information is submitted to
CDC by mailing or faxing a written
report on the respondent’s letterhead.
All faxed lists should be followed up
with a mailed original. Data may also be
submitted to CDC by CD, three-inch
floppy disk, or thumb drive. Electronic
mail submissions are not accepted. Mail
Annual Ingredient Submissions to
Attention: FCLAA Program Manager,
Office on Smoking and Health, National
Center for Chronic Disease Prevention
and Health Promotion, Centers for
Disease Control and Prevention, 4770
Buford Highway, NE, MS S107–7,
Atlanta, GA 30341–3717
Upon receipt and verification of the
annual ingredient report, CDC issues a
Certificate of Compliance to the
respondent. As deemed appropriate by
the Secretary of HHS, HHS is authorized
to use the information to report to
Congress the health effects of
ingredients, research activities related to
the health effects of ingredients, and
other information that the Secretary
determines to be of public interest.
There are no costs to respondents other
E:\FR\FM\21AUN1.SGM
21AUN1
42300
Federal Register / Vol. 83, No. 162 / Tuesday, August 21, 2018 / Notices
than their time. The total estimated
annualized burden hours are 358. OMB
approval is requested for three years.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Form name
Business Entities ................................................................
N/A ..................
55
1
6.5
358
Total ............................................................................
..........................
........................
........................
........................
358
Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2018–17978 Filed 8–20–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60-Day–18–0488; Docket No. CDC–2018–
0071]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Report of Illness or Death
Interstate Travel of Persons (42 CFR part
70) (OMB Control Number 0920–0488,
Expiration Date 5/31/2019) which
specifies the required reporting of ill
persons or deaths occurring during
interstate travel, primarily air travel.
DATES: CDC must receive written
comments on or before October 22,
2018.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2018–
0071 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
sradovich on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:31 Aug 20, 2018
Jkt 244001
Number of
respondents
Average
burden per
response
(in hours)
Type of
respondents
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road, NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffery M. Zorger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
Total burden
(in hours)
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Report of Illness or Death Interstate
Travel of Persons (42 CFR part 70)—
Revision—National Center for Emerging
and Zoonotic Infectious Diseases
(NCEZID), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Section 361 of the Public Health
Service Act (42 U.S.C. 264) authorizes
the Secretary of the Department of
Health and Human Services to make
and enforce regulations necessary to
prevent the introduction, transmission,
or spread of communicable diseases
from foreign countries into the United
States, or from one State or possession
into any other State or possession. CDC
administers regulations pertaining to
interstate control of communicable
diseases (42 CFR part 70), and sections
42 CFR parts 70.4 and 70.11 include
requirements reports of ill persons or
death if occurring during interstate
travel.
The intended use of the information
is to ensure that CDC can assess and
respond to reports of ill persons or
death that occur on conveyances
engaged in interstate travel, and assist
state and local health authorities if an
illness or death occurs that poses a risk
to public health. Generally, the primary
source of this information is aircraft
traveling within the United States.
For reports of ill persons or death on
a conveyance engaged in interstate
E:\FR\FM\21AUN1.SGM
21AUN1
]]>Agencies
[Federal Register Volume 83, Number 162 (Tuesday, August 21, 2018)]
[Notices]
[Pages 42299-42300]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-17978]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60-Day-18-0210; Docket No. CDC-2018-0069]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a continuing
information collection project titled List of Ingredients Added to
Tobacco in the Manufacture of Cigarette Products.
DATES: CDC must receive written comments on or before October 22, 2018.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2018-
0069 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road,
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (egulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffery M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road, NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
List of Ingredients Added to Tobacco in the Manufacture of
Cigarette Products--Extension (OMB# 0920-0210 Exp.Date 12/31/2018)--
National Center for Chronic Disease Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Cigarette smoking is the leading preventable cause of premature
death and disability in our Nation. Each year more than 480,000 deaths
occur as the result of cigarette smoking-related diseases.
The CDC's Office on Smoking and Health (OSH) has the primary
responsibility for the HHS smoking and health program. Since 1986, as
required by the Comprehensive Smoking Education Act (CSEA) of 1984,
which amended the Federal Cigarette Labeling and Advertising Act, 15
U.S.C. 1335a, CDC has collected information about the ingredients used
in cigarette products. HHS has delegated responsibility for
implementing the required information collection to CDC's OSH.
Respondents are commercial cigarette manufacturers, packagers, or
importers (or their representatives), who are required by the CSEA to
submit ingredient reports to HHS on an annual basis.
Respondents are not required to submit specific forms; however,
they are required to submit a list of all ingredients used in their
products. CDC requires the ingredient report to be submitted by
chemical name and Chemical Abstract Service (CAS) Registration Number,
consistent with accepted reporting practices for other companies
currently required to report ingredients added to other consumer
products. The information collected is subject to strict
confidentiality provisions.
Ingredient reports are due annually on March 31. Information is
submitted to CDC by mailing or faxing a written report on the
respondent's letterhead. All faxed lists should be followed up with a
mailed original. Data may also be submitted to CDC by CD, three-inch
floppy disk, or thumb drive. Electronic mail submissions are not
accepted. Mail Annual Ingredient Submissions to Attention: FCLAA
Program Manager, Office on Smoking and Health, National Center for
Chronic Disease Prevention and Health Promotion, Centers for Disease
Control and Prevention, 4770 Buford Highway, NE, MS S107-7, Atlanta, GA
30341-3717
Upon receipt and verification of the annual ingredient report, CDC
issues a Certificate of Compliance to the respondent. As deemed
appropriate by the Secretary of HHS, HHS is authorized to use the
information to report to Congress the health effects of ingredients,
research activities related to the health effects of ingredients, and
other information that the Secretary determines to be of public
interest. There are no costs to respondents other
[[Page 42300]]
than their time. The total estimated annualized burden hours are 358.
OMB approval is requested for three years.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondents Form name respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
Business Entities............. N/A............. 55 1 6.5 358
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 358
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Acting Chief, Information Collection Review Office, Office of
Scientific Integrity, Office of the Associate Director for Science,
Office of the Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-17978 Filed 8-20-18; 8:45 am]
BILLING CODE 4163-18-P
